Mani Foroohar
Stock Analyst at Leerink Partners
(0.21)
# 4,589
Out of 5,020 analysts
946
Total ratings
43.6%
Success rate
-4.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mani Foroohar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCKT Rocket Pharmaceuticals | Reiterated: Hold | n/a | $2.59 | - | 56 | Sep 16, 2026 | |
| ENGN enGene Therapeutics | Reiterated: Hold | $2 | $1.99 | +0.76% | 14 | Sep 9, 2026 | |
| ABSI Absci | Initiated Coverage: Buy | $12 | $10.75 | +11.63% | 1 | Jun 4, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $100 → $154 | $83.92 | +83.51% | 54 | May 15, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $17 | $7.42 | +129.11% | 64 | May 15, 2026 | |
| NTLA Intellia Therapeutics | Reiterated: Buy | $27 → $35 | $12.12 | +188.78% | 52 | Apr 27, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $8 → $9 | $3.84 | +134.38% | 7 | Apr 2, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Hold | n/a | $64.79 | - | 56 | Mar 26, 2026 | |
| MRNA Moderna | Reiterated: Sell | $12 | $188.94 | -93.65% | 89 | Feb 11, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Hold | $370 → $351 | $231.18 | +51.83% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $86 | $66.91 | +28.53% | 76 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $100 | $44.00 | +127.27% | 67 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $2 | $0.5657 | +253.54% | 16 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $18 | $3.62 | +397.24% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $74 | $55.44 | +33.48% | 27 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.84 | - | 41 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.07 | - | 34 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $48 | $46.16 | n/a | 2 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $9.58 | n/a | 9 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.39 | n/a | 20 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $27 | $30.46 | n/a | 12 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.22 | n/a | 32 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $26.55 | n/a | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.52 | n/a | 20 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.85 | n/a | 31 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.14 | n/a | 3 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $3.79 | n/a | 15 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $38.87 | n/a | 1 | Jun 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $3.88 | n/a | 24 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $6 | $5.01 | n/a | 17 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $22.67 | n/a | 7 | Oct 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $216 → $197 | $17.57 | n/a | 3 | Nov 6, 2020 |
Rocket Pharmaceuticals
Sep 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.59
Upside: -
enGene Therapeutics
Sep 9, 2026
Reiterated: Hold
Price Target: $2
Current: $1.99
Upside: +0.76%
Absci
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $10.75
Upside: +11.63%
Mirum Pharmaceuticals
May 15, 2026
Reiterated: Buy
Price Target: $100 → $154
Current: $83.92
Upside: +83.51%
REGENXBIO
May 15, 2026
Reiterated: Buy
Price Target: $17
Current: $7.42
Upside: +129.11%
Intellia Therapeutics
Apr 27, 2026
Reiterated: Buy
Price Target: $27 → $35
Current: $12.12
Upside: +188.78%
Camp4 Therapeutics
Apr 2, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $3.84
Upside: +134.38%
Arrowhead Pharmaceuticals
Mar 26, 2026
Reiterated: Hold
Price Target: n/a
Current: $64.79
Upside: -
Moderna
Feb 11, 2026
Reiterated: Sell
Price Target: $12
Current: $188.94
Upside: -93.65%
Alnylam Pharmaceuticals
Dec 15, 2025
Reiterated: Hold
Price Target: $370 → $351
Current: $231.18
Upside: +51.83%
Dec 15, 2025
Reiterated: Buy
Price Target: $370 → $86
Current: $66.91
Upside: +28.53%
Dec 15, 2025
Reiterated: Buy
Price Target: $68 → $100
Current: $44.00
Upside: +127.27%
Dec 15, 2025
Reiterated: Buy
Price Target: $3 → $2
Current: $0.5657
Upside: +253.54%
Oct 21, 2025
Reiterated: Buy
Price Target: $20 → $18
Current: $3.62
Upside: +397.24%
Oct 15, 2025
Reiterated: Buy
Price Target: $56 → $74
Current: $55.44
Upside: +33.48%
Oct 15, 2025
Reiterated: Buy
Price Target: n/a
Current: $13.84
Upside: -
Oct 15, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.07
Upside: -
Sep 25, 2025
Reiterated: Buy
Price Target: $51 → $48
Current: $46.16
Upside: n/a
Sep 23, 2025
Reiterated: Buy
Price Target: $20
Current: $9.58
Upside: n/a
Sep 3, 2025
Reiterated: Buy
Price Target: n/a
Current: $24.39
Upside: n/a
Aug 18, 2025
Reiterated: Buy
Price Target: $32 → $27
Current: $30.46
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $3
Current: $1.22
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $70
Current: $26.55
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $1
Current: $2.52
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $1
Current: $2.85
Upside: n/a
Jul 15, 2024
Reiterated: Buy
Price Target: n/a
Current: $7.14
Upside: n/a
Nov 13, 2023
Reiterated: Hold
Price Target: $21
Current: $3.79
Upside: n/a
Jun 8, 2023
Reiterated: Sell
Price Target: n/a
Current: $38.87
Upside: n/a
May 23, 2023
Reiterated: Hold
Price Target: $6 → $5
Current: $3.88
Upside: n/a
Nov 14, 2022
Reiterated: Hold
Price Target: $5 → $6
Current: $5.01
Upside: n/a
Oct 19, 2021
Reiterated: Hold
Price Target: n/a
Current: $22.67
Upside: n/a
Nov 6, 2020
Reiterated: Buy
Price Target: $216 → $197
Current: $17.57
Upside: n/a